{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:45:36Z","timestamp":1784317536890,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.ajo.2008.08.016","type":"journal-article","created":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T04:18:34Z","timestamp":1224303514000},"page":"298-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion"],"prefix":"10.1016","volume":"147","author":[{"given":"Richard F.","family":"Spaide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis K.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Klancnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Yannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sorenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Slakter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Bailey","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2008.08.016_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archopht.126.4.513","article-title":"The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study","volume":"126","author":"Klein","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archopht.124.5.726","article-title":"Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study","volume":"124","author":"Cugati","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib3","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archopht.121.9.1297","article-title":"Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire","volume":"121","author":"Deramo","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2008.08.016_bib5","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/archopht.120.12.1644","article-title":"Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion","volume":"120","author":"Boyd","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib6","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","article-title":"Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate","volume":"103","author":"Tolentino","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2008.08.016_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","article-title":"Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate","volume":"114","author":"Adamis","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/archopht.123.2.214","article-title":"An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization","volume":"123","author":"Bhisitkul","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ajo.2008.08.016_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","article-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study","volume":"26","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2008.08.016_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IAE.0b013e31802eff83","article-title":"Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO Study","volume":"27","author":"Costa","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2008.08.016_bib12","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajo.2007.07.038","article-title":"Early bevacizumab treatment of central retinal vein occlusion","volume":"144","author":"Ferrara","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2008.08.016_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ajo.2004.07.050","article-title":"Evaluation of image artifact produced by optical coherence tomography of retinal pathology","volume":"139","author":"Ray","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib15","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.ophtha.2007.09.017","article-title":"Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients","volume":"114","author":"Alexander","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2008.08.016_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/112067219900900305","article-title":"Central retinal vein occlusion: report of two familial cases","volume":"9","author":"Bhagat","year":"1999","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib17","first-page":"760","article-title":"Tractional detachment of the macula following branch retinal vein occlusion","volume":"15","author":"Murakami","year":"1983","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00417-006-0508-y","article-title":"Horseshoe-like macular tear following recurrent branch retinal vein occlusion","volume":"245","author":"Karim-Zade","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0161-6420(00)00512-1","article-title":"Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion","volume":"108","author":"Amirikia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2008.08.016_bib20","first-page":"284","article-title":"Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion","volume":"31","author":"Stef\u00e1nsson","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2008.08.016_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0161-6420(83)34530-9","article-title":"Classification of central retinal vein occlusion","volume":"90","author":"Hayreh","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2008.08.016_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archopht.1997.01100150488006","article-title":"Natural history and clinical management of central retinal vein occlusion","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0161-6420(95)30848-2","article-title":"A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2008.08.016_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0002-9394(01)01381-2","article-title":"Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate","volume":"133","author":"Tolentino","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.1978.03910050179015","article-title":"Experimental retinal vascular occlusion","volume":"96","author":"Hayreh","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.08.016_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajo.2008.08.016_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajo.2007.02.024","article-title":"Ranibizumab according to need: a treatment for age-related macular degeneration","volume":"143","author":"Spaide","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408006594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408006594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:57:10Z","timestamp":1757595430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939408006594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0002939408006594"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2008.08.016","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2008.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}